We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current AZYO market cap is 28.09M. The company's latest EPS is USD -1.9973 and P/E is -1.39.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 12.39M | 12.67M | 13.05M | 10.3M | -4.48M |
| Operating Income | -7.79M | -8.84M | -6.42M | -9.09M | -6.52M |
| Net Income | -9.91M | -5.44M | -7.97M | -10.62M | -9.75M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 42.9M | 42.68M | 47.39M | 49.19M | 24.75M |
| Operating Income | -8.41M | -13.6M | -23.03M | -31.74M | -30.53M |
| Net Income | -11.94M | -25.34M | -24.83M | -32.9M | -37.66M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 61.02M | 68.84M | 60.63M | 52.33M | 54.58M |
| Total Liabilities | 71.7M | 73.87M | 72.81M | 74.46M | 84.05M |
| Total Equity | -10.68M | -5.03M | -12.18M | -22.13M | -29.47M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 44.77M | 82.81M | 67.17M | 68.84M | 43.43M |
| Total Liabilities | 55.43M | 61.98M | 53.65M | 73.87M | 82.03M |
| Total Equity | -55.11M | 20.83M | 13.52M | -5.03M | -38.6M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.19M | -21.43M | -5.17M | -7.56M | -12.68M |
| Investing | -406k | -540k | -182k | -267k | -329k |
| Financing | -5.73M | 8.54M | 148k | 129k | 10.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.23M | -13.63M | -15.45M | -21.43M | -21.76M |
| Investing | -577k | -640k | -369k | -540k | 14.21M |
| Financing | 7.98M | 51.21M | 6.71M | 8.54M | 9.84M |
| Market Cap | 28.09M |
| Price to Earnings Ratio | -1.39 |
| Price to Sales Ratio | 2.12 |
| Price to Cash Ratio | 2.72 |
| Price to Book Ratio | -1.36 |
| Dividend Yield | - |
| Shares Outstanding | 18.85M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -15.34% |
| 52 Week High | 2.80 |
| 52 Week Low | 1.26 |
| Spread (Intraday) | 0.04 (2.61%) |
| Company Name | Aziyo Biologics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.elutia.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
